Exosomes for Hair Loss | How to Read the Evidence Before Paying
Written and reviewed by the clinical team at The Wellness
Direct answer
Early clinical studies of exosome treatments for hair loss report promising changes, but the evidence is small and varied. Results from one preparation or delivery method cannot automatically be applied to another. Ask about the exact treatment, its clinical evidence, uncertainty, risks and alternatives before paying for a course.
Start with the cause of the hair loss
A treatment discussion should begin with a diagnosis. Different causes of hair loss need different approaches, and not every person with thinning hair is a candidate for an emerging treatment. Bring a timeline of the loss, relevant medical history, medicines and previous treatments. Ask what the doctor thinks is causing the change and what other assessment is needed before deciding on injections.
What exosomes are, in plain language
Exosomes are small particles released by cells that carry biological signals. Interest in hair treatment comes from their possible effects on the processes around hair follicles. That biological rationale is a reason to study them; it is not proof that a particular clinic product will regrow hair. Exosome preparations differ in their source, processing and contents. The word “exosome” does not describe one standardized treatment.
What the clinical reviews show
A systematic review in World Journal of Stem Cells included 27 studies, but only three were clinical studies. Much of the evidence concerned laboratory or animal research. Another systematic review in Clinical, Cosmetic and Investigational Dermatology included 11 clinical studies, with only two randomized controlled trials. Many of the other studies were small, uncontrolled or retrospective. Follow-up and outcome measures varied. These limitations matter when deciding how much confidence to place in a headline or before-and-after photograph.
Why the exact preparation and delivery matter
Evidence for one preparation cannot establish results for every product sold under the same treatment name. Ask whether the study used the same preparation, concentration, delivery route and treatment schedule being offered to you. Topical application, microneedling and injections are not interchangeable for interpreting evidence. Combining several treatments also makes it harder to know which part produced a change.
Separate improvement from a guarantee
A change in hair count or thickness in a study does not tell you that everyone will achieve visible regrowth. Ask how improvement will be measured, when it will be reviewed and what happens if there is little benefit. Standardized photographs can support monitoring when lighting, hair position and camera angle are kept consistent. Photos are not a substitute for controlled clinical evidence, and a clinic should not guarantee a result.
What is known about safety, and what is not
The clinical review reported mostly mild, temporary local effects and no serious systemic adverse events in the included studies. Small samples and short follow-up cannot rule out uncommon or delayed harms. Product quality, sterility and delivery technique are separate safety questions. Ask the clinician to explain known risks, what remains uncertain, what documentation supports the preparation being used and what you should do if a problem occurs. “Cell-free” does not mean “risk-free.”
Compare the whole plan, not one session
Discuss established options appropriate to your diagnosis, as well as doing nothing or waiting. Ask whether an emerging treatment is replacing an evidence-supported option or being proposed alongside it, and why. Obtain the planned number of sessions, review point, total price and any additional charges in writing. Avoid buying a large course before you understand the uncertainty and the alternatives.
A checklist to take to the consultation
Ask: What is my diagnosis? Which exact preparation and delivery method are you proposing? Which human studies support this plan? How long were patients followed? What are the risks and unknowns? What alternatives fit my diagnosis? How will we decide whether it is helping? What happens if it does not help? You should have time to consider the answers. A careful recommendation may be to investigate first or choose a different treatment.
Frequently asked questions
Are exosomes proven to regrow hair for everyone?
No. Early studies are promising, but small and varied studies do not establish reliable benefit for every patient or preparation.
Can research on one exosome product prove another works?
No. The preparation, delivery route, dose and treatment schedule may differ. Ask how the evidence relates to the exact treatment offered.
Does no serious harm in a small study prove long-term safety?
No. Small samples and limited follow-up may miss uncommon or delayed harms.
Sources
World Journal of Stem Cells | Exosomes and hair regeneration review — https://www.wjgnet.com/1948-0210/abstract/v17/i7/108519.htm
Clinical, Cosmetic and Investigational Dermatology | Clinical evidence review — https://www.dovepress.com/exosomes-and-hair-regeneration-a-systematic-review-of-clinical-evidenc-peer-reviewed-fulltext-article-CCID
GMC | Cosmetic intervention guidance — https://www.gmc-uk.org/professional-standards/professional-standards-for-doctors/cosmetic-interventions
Next step
For nonemergency advice, contact the clinical team. London appointments are at 10 Portman Square, London W1H 6AZ. A consultation does not guarantee a prescription or procedure.
Discuss suitability with the clinical team: https://www.thelondonprpclinic.com/contact
See current treatment information: https://www.thelondonprpclinic.com/services
This article provides general information and does not replace individual medical advice.